The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

117.12

+0.16

(+0.14%)

At close: 04:00PM EDT

116.99

-0.13

(-0.11%)

After hours:

07:11PM EDT

Currency in USD

Earnings estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	13	13	15	16
Avg. Estimate	-0.07	-0.13	2.29	10.55
Low estimate	-0.64	-0.66	-1.83	-1.64
High estimate	0.35	0.74	6.77	24.27
Year ago EPS	-5.86	-0.27	-5.8	2.29

Revenue estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	16	16	20	20
Avg. Estimate	373.28M	385.24M	1.85B	2.82B
Low estimate	299.5M	286.5M	1.51B	1.5B
High estimate	403.85M	440M	2.37B	4.72B
Year ago sales	253.5M	261.24M	1.24B	1.85B
Sales growth (year/est)	47.30%	47.50%	48.70%	52.60%

Earnings history	30/03/2023	29/06/2023	29/09/2023	30/12/2023
Est. EPS	-1.38	-1.78	-1.23	0.01
Actual EPS	-5.86	-0.27	-0.46	0.47
Difference	-4.48	1.51	0.77	0.46
Surprise %	-324.60%	84.80%	62.60%	4,600.00%

EPS trend	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Current estimate	-0.07	-0.13	2.29	10.55
7 days ago	-0.07	-0.12	2.4	11.04
30 days ago	-0.05	-0.06	2.37	10.94
60 days ago	-0.3	0.26	2.53	8.85
90 days ago	-0.03	0.29	2.96	10.13

EPS revisions	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Up last 7 days	1	N/A	1	N/A
Up last 30 days	1	N/A	1	1
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	1	N/A	N/A

Growth estimates	SRPT	Industry	Sector(s)	S&P 500
Current qtr.	98.80%	N/A	N/A	N/A
Next qtr.	51.90%	N/A	N/A	N/A
Current year	139.50%	N/A	N/A	N/A
Next year	360.70%	N/A	N/A	N/A
Next 5 years (per annum)	96.00%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A